Tannert Line Kring, Mortz Charlotte Gotthard, Skov Per Stahl, Bindslev-Jensen Carsten
Odense Research Center for Anaphylaxis, Odense, Denmark; Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark.
Odense Research Center for Anaphylaxis, Odense, Denmark; Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark.
J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):676-683. doi: 10.1016/j.jaip.2017.03.014.
According to guidelines, patients are diagnosed with penicillin allergy if skin test (ST) result or specific IgE (s-IgE) to penicillin is positive. However, the true sensitivity and specificity of these tests are presently not known.
To investigate the clinical relevance of a positive ST result and positive s-IgE and to study the reproducibility of ST and s-IgE.
A sample of convenience of 25 patients with positive penicillin ST results, antipenicillin s-IgE results, or both was challenged with their culprit penicillin. Further 19 patients were not challenged, but deemed allergic on the basis of a recent anaphylactic reaction or delayed reactions to skin testing. Another sample of convenience of 18 patients, 17 overlapping with the 25 challenged, with initial skin testing and s-IgE (median, 25; range, 3-121), months earlier (T), was repeat skin tested and had s-IgE measured (T), and then skin tested and had s-IgE measured 4 weeks later (T).
Only 9 (36%) of 25 were challenge positive. There was an increased probability of being penicillin allergic if both ST result and s-IgE were positive at T. Positive ST result or positive s-IgE alone did not predict penicillin allergy. Among the 18 patients repeatedly tested, 46.2% (12 of 25) of positive ST results at T were reproducibly positive at T. For s-IgE, 54.2% (14 of 24) positive measurements were still positive at T and 7 converted to positive at T.
The best predictor for a clinically significant (IgE-mediated) penicillin allergy is a combination of a positive case history with simultaneous positive ST result and s-IgE or a positive challenge result.
根据指南,如果皮肤试验(ST)结果或青霉素特异性IgE(s-IgE)呈阳性,则患者被诊断为青霉素过敏。然而,目前尚不清楚这些检测的真正敏感性和特异性。
研究ST结果阳性和s-IgE阳性的临床相关性,并探讨ST和s-IgE的可重复性。
对25例青霉素ST结果阳性、抗青霉素s-IgE结果阳性或两者均阳性的患者进行便利抽样,用其致病青霉素进行激发试验。另外19例患者未进行激发试验,但基于近期过敏反应或皮肤试验延迟反应被判定为过敏。另一组便利抽样的18例患者,其中17例与25例接受激发试验的患者重叠,数月前(T1)进行了初始皮肤试验和s-IgE检测(中位数为25;范围为3-121),之后重复进行皮肤试验并检测s-IgE(T2),然后在4周后再次进行皮肤试验并检测s-IgE(T3)。
25例患者中只有9例(36%)激发试验阳性。如果T1时ST结果和s-IgE均为阳性,则青霉素过敏的可能性增加。单独的ST结果阳性或s-IgE阳性并不能预测青霉素过敏。在18例重复检测的患者中,T1时46.2%(25例中的12例)的ST结果阳性在T2时仍为阳性。对于s-IgE,54.2%(24例中的14例)的阳性检测结果在T2时仍为阳性,7例在T3时转为阳性。
对于临床上有意义的(IgE介导的)青霉素过敏,最佳预测指标是阳性病史同时伴有ST结果和s-IgE阳性或激发试验阳性。